Skip to main content
. 2024 Feb 28;13(3):215. doi: 10.3390/pathogens13030215

Table 3.

Prevalence (%) by age group and sex. CI 95% (lower–upper).

Age Group Sex Screened HCVAb+ Prevalence CI 95% HCV RNA+ Prevalence CI 95%
30–39 F 559 1 0.179 0.005–0.993
M 274 3 1.100 0.226–3.166
40–49 F 1058 5 0.473 0.154–1.10 1 0.095 0.0024–0.525
M 545 3 0.550 0.114–1.600
≥50 F 518 7 1.350 0.545–2.764 1 0.193 0.0049–1.07
M 336 12 3.448 1.645–5.782 3 0.893 0.185–2.59